Cardiac Allograft Remodeling and Effects of Sirolimus (CAR)
Cardiac Allograft Remodeling and Effects of Sirolimus on Its Progression
Sponsor: University of Nebraska
Terminated
PI left University and project not continued
Other terminated trials from University of Nebraska
A PHASE1 clinical study on Cardiac Hypertrophy and Immunosuppression, this trial is terminated or withdrawn. The trial is conducted by University of Nebraska and has accumulated 9 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Sep 2023 — Jul 2024 [monthly]
Terminated PHASE1
-
Aug 2023 — Sep 2023 [monthly]
Terminated PHASE1
Status: Suspended → Terminated
-
Jan 2023 — Aug 2023 [monthly]
Suspended PHASE1
▶ Show 4 earlier versions
-
Jan 2021 — Jan 2023 [monthly]
Suspended PHASE1
-
Jan 2020 — Jan 2021 [monthly]
Suspended PHASE1
Status: Unknown Status → Suspended
-
Jun 2018 — Jan 2020 [monthly]
Unknown Status PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE1
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Nebraska
For direct contact, visit the study record on ClinicalTrials.gov .